Back
Cemtrex, Inc. 10K Form
Sell
21
CETX
Cemtrex, Inc.
Last Price:
$2.60
Seasonality Move:
1.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-10 | 10Q | CETX/Cemtrex, Inc. Quarterly |
| 2023-05-11 | 10Q | CETX/Cemtrex, Inc. Quarterly |
| 2023-02-14 | 10Q | CETX/Cemtrex, Inc. Quarterly |
| 2022-08-15 | 10Q | CETX/Cemtrex, Inc. Quarterly |
| 2022-05-16 | 10Q | CETX/Cemtrex, Inc. Quarterly |
| 2022-02-18 | 10Q | CETX/Cemtrex, Inc. Quarterly |
Receive CETX News And Ratings
See the #1 stock for the next 7 days that we like better than CETX
CETX Financial Statistics
Sales & Book Value
| Annual Sales: | $76.5M |
|---|---|
| Cash Flow: | $1.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.03 |
| Price / Book: | 1.85 |
Profitability
| EPS (TTM): | 2194.16000 |
|---|---|
| Net Income (TTM): | $-20.3M |
| Gross Margin: | $30.9M |
| Return on Equity: | -704.08% |
| Return on Assets: | -44.51% |
Cemtrex, Inc. Earnings Forecast
Key Cemtrex, Inc. Financial Ratios
-
The Gross Profit Margin over the past 19 years for CETX is 40.44%.
-
The Selling, General & Administrative Expenses for CETX have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 3.08% of Revenue.
-
The Net Earning history of CETX is -36.67% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
Cemtrex, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Electronic Equipment, Instruments & Components |
| Sector: | Information Technology |
| Current Symbol: | CETX |
| CUSIP: | 15130G |
| Website: | cemtrex.com |
Debt
| Debt-to-Equity Ratio: | 6.24 |
|---|---|
| Current Ratio: | 1.2 |
| Quick Ratio: | 0.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CETX Technical Analysis vs Fundamental Analysis
Sell
21
Cemtrex, Inc. (CETX)
is a Sell
Is Cemtrex, Inc. a Buy or a Sell?
-
Cemtrex, Inc. stock is rated a SellThe current Cemtrex, Inc. [CETX] share price is $2.59. The Score for CETX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.